EVH - Evolent Health Inc. (EVH) Q1 2024 Earnings Call Transcript
2024-05-09 21:13:02 ET
Evolent Health, Inc. (EVH)
Q1 2024 Results Conference Call
May 9, 2024 5:00 PM ET
Company Participants
Seth Frank - Vice President of Investor Relations
Seth Blackley - Chief Executive Officer, Co-Founder and Board Member
John Johnson - Chief Financial Officer
Conference Call Participants
Kyle Aikman - JPMorgan
Jeff Garro - Stephens
Kevin Caliendo - UBS
Charles Rhyee - TD Cowen
Jessica Tassan - Piper Sandler
Ryan Daniels - William Blair
Jailendra Singh - Truist Securities
Sean Dodge - RBC Capital Markets
Daniel Grosslight - Citi
Jack Wallace - Guggenheim
Stephanie Davis - SVB Leerink
David Larsen - BTIG
Presentation
Operator
Welcome to the Evolent Earnings Conference Call for the First Quarter Ended March 31, 2024. As a reminder, this conference call is being recorded. Your hosts for the call today from Evolent are Seth Blackley, Chief Executive Officer; and John Johnson, Chief Financial Officer. This call will be archived and available later this evening, and for the next week via the webcast on the company's website and the section titled Investor Relations.
I will now hand the call to Seth Frank, Evolent's, Vice President of Investor Relations. Please go ahead.
Seth Frank
Thank you, and good evening. This conference call will contain forward looking statements under the U.S. Federal laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations.
A description of some of the risks and uncertainties can be found in the company's reports with filed with the Securities and Exchange Commission, including cautionary statements included in our current and periodic filings. For additional information on the company's results and outlook, please refer to our first quarter press release issued earlier today.
Finally, as a reminder, reconciliations of non-GAAP measures discussed during today's call to the most direct comparable GAAP measures are available in the summary presentation, available in the Investor Relations section of our website or in the company's press release issued today, and posted on the IR section of the company's website ir.evolenthealth.com and the Form 8-K filed by the company with the SEC earlier today.
Finally, in addition to the reconciliations, we've provided details on the numbers and operating metrics for the quarter in both our press release and our supplemental investor presentation on the IR website....
Evolent Health, Inc. (EVH) Q1 2024 Earnings Call Transcript